Symbols / IRMD Stock $87.20 -2.11% IRADIMED CORPORATION

Healthcare • Medical Devices • United States • NGM
IRMD (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Devices
CEO Mr. Roger E. Susi
Exch · Country NGM · United States
Market Cap 1.11B
Enterprise Value 1.09B
Income 22.48M
Sales 83.81M
FCF (ttm) 6.64M
Book/sh 7.40
Cash/sh 4.00
Employees 166
Insider 10d —
IPO Jul 16, 2014
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 38.86%
P/E 49.83
Forward P/E 37.59
PEG —
P/S 13.30
P/B 11.78
P/C —
EV/EBITDA 39.82
EV/Sales 12.97
Quick Ratio 6.37
Current Ratio 7.98
Debt/Eq —
LT Debt/Eq —
EPS (ttm) 1.75
EPS next Y 2.32
EPS Growth 24.80%
Revenue Growth 17.00%
EPS Gr Q/Q 25.20%
Rev Gr Q/Q —
Earnings (next) 2026-05-01
Earnings (prior) 2026-02-10
ROA 15.78%
ROE 24.78%
ROIC —
Gross Margin 76.75%
Oper. Margin 31.26%
Profit Margin 26.82%
Shs Outstand 12.78M
Shs Float 8.27M
Insider Own 36.61%
Instit Own 59.54%
Short Float 6.67%
Short Ratio 5.57
Short Interest 540.18K
52W High 107.90
vs 52W High -19.18%
52W Low 50.31
vs 52W Low 73.33%
Beta 1.12
Impl. Vol. 59.57%
Rel Volume 0.66
Avg Volume 80.81K
Volume 53.55K
Target (mean) $118.67
Tgt Median $120.00
Tgt Low $116.00
Tgt High $120.00
# Analysts 3
Recom None
Prev Close $89.08
Price $87.20
Change -2.11%
About

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors in the United States and internationally. The company was incorporated in 1992 and is headquartered in Orlando, Florida.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$118.67
Mean price target
2. Current target
$87.20
Latest analyst target
3. DCF / Fair value
$9.35
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$87.20
Low
$116.00
High
$120.00
Mean
$118.67

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-02 init Freedom Broker — → Buy $116
2025-02-14 reit Roth MKM Buy → Buy $72
2024-08-02 main Roth MKM Buy → Buy $60
2021-08-02 main Roth Capital — → Buy $36
2017-07-31 up Roth Capital Neutral → Buy —
2016-10-05 down Roth Capital Buy → Neutral —
2016-04-04 main Roth Capital — → Buy $25
2015-06-16 main Roth Capital — → Buy $23
2014-08-11 init Roth Capital — → — $14
News
RSS: Latest IRMD news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-21 SUSI ROGER E Chief Executive Officer — 7,500 $89.73 $694,124
2026-04-14 SUSI ROGER E Chief Executive Officer — 7,500 $91.84 $697,189
2026-04-07 SUSI ROGER E Chief Executive Officer — 7,500 $94.36 $717,208
2026-03-30 SUSI ROGER E Chief Executive Officer — 7,500 $94.81 $712,614
2026-03-24 SUSI ROGER E Chief Executive Officer — 7,500 $99.58 $752,609
2026-03-17 SUSI ROGER E Chief Executive Officer — 7,500 $101.18 $762,970
2026-03-10 SUSI ROGER E Chief Executive Officer — 7,500 $100.04 $750,475
2026-03-06 SUSI ROGER E Chief Executive Officer — 7,500 $98.25 $737,919
2026-02-13 ALLEN MONTY K Director — 1,000 $100.26 $100,256
2026-01-26 SUSI ROGER E Chief Executive Officer — 5,000 $100.54 $503,255
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
83.81
+14.43%
73.24
+11.71%
65.56
+23.00%
53.30
Operating Revenue
83.81
+14.43%
73.24
+11.71%
65.56
+23.00%
53.30
Cost Of Revenue
19.49
+15.38%
16.89
+9.66%
15.40
+28.15%
12.02
Reconciled Cost Of Revenue
19.49
+15.38%
16.89
+9.66%
15.40
+28.15%
12.02
Gross Profit
64.32
+14.15%
56.35
+12.34%
50.16
+21.50%
41.28
Operating Expense
38.18
+11.03%
34.38
+14.15%
30.12
+17.42%
25.65
Research And Development
2.98
+5.05%
2.83
-0.93%
2.86
+25.49%
2.28
Selling General And Administration
35.20
+11.56%
31.55
+15.73%
27.26
+16.63%
23.38
Selling And Marketing Expense
17.42
+11.55%
15.62
+28.61%
12.14
-4.24%
12.68
General And Administrative Expense
17.78
+11.58%
15.94
+5.39%
15.12
+41.37%
10.70
Other Gand A
17.78
+11.58%
15.94
+5.39%
15.12
+41.37%
10.70
Total Expenses
57.67
+12.46%
51.28
+12.63%
45.53
+20.84%
37.68
Operating Income
26.15
+19.04%
21.96
+9.63%
20.04
+28.21%
15.63
Total Operating Income As Reported
26.15
+19.04%
21.96
+9.63%
20.04
+28.21%
15.63
EBITDA
27.31
+19.88%
22.78
+9.53%
20.80
+27.62%
16.30
Normalized EBITDA
27.11
+18.74%
22.83
+8.91%
20.96
+28.39%
16.33
Reconciled Depreciation
1.17
+42.54%
0.82
+6.90%
0.77
+14.09%
0.67
EBIT
26.15
+19.04%
21.96
+9.63%
20.04
+28.21%
15.63
Total Unusual Items
0.20
+536.17%
-0.05
+70.86%
-0.16
-461.13%
-0.03
Total Unusual Items Excluding Goodwill
0.20
+536.17%
-0.05
+70.86%
-0.16
-461.13%
-0.03
Special Income Charges
0.20
+5175.00%
-0.00
+67.93%
-0.01
0.00
Net Income
22.48
+16.88%
19.23
+11.87%
17.19
+34.02%
12.83
Pretax Income
28.36
+16.83%
24.27
+11.67%
21.74
+34.35%
16.18
Net Non Operating Interest Income Expense
2.01
-8.39%
2.19
+17.64%
1.86
+220.38%
0.58
Net Interest Income
2.01
-8.39%
2.19
+17.64%
1.86
+220.38%
0.58
Interest Income Non Operating
2.01
-8.39%
2.19
+17.64%
1.86
+220.38%
0.58
Interest Income
2.01
-8.39%
2.19
+17.64%
1.86
+220.38%
0.58
Other Income Expense
0.20
+75.21%
0.12
+172.53%
-0.16
-461.13%
-0.03
Other Non Operating Income Expenses
—
0.16
—
—
Gain On Sale Of Security
0.00
+104.65%
-0.04
+71.11%
-0.15
-417.75%
-0.03
Tax Provision
5.88
+16.66%
5.04
+10.90%
4.55
+35.59%
3.35
Tax Rate For Calcs
0.00
-0.32%
0.00
-0.64%
0.00
+0.97%
0.00
Tax Effect Of Unusual Items
0.04
+534.78%
-0.01
+71.05%
-0.03
-466.56%
-0.01
Net Income Including Noncontrolling Interests
22.48
+16.88%
19.23
+11.87%
17.19
+34.02%
12.83
Net Income From Continuing Operation Net Minority Interest
22.48
+16.88%
19.23
+11.87%
17.19
+34.02%
12.83
Net Income From Continuing And Discontinued Operation
22.48
+16.88%
19.23
+11.87%
17.19
+34.02%
12.83
Net Income Continuous Operations
22.48
+16.88%
19.23
+11.87%
17.19
+34.02%
12.83
Normalized Income
22.32
+15.81%
19.27
+11.26%
17.32
+34.78%
12.85
Net Income Common Stockholders
22.48
+16.88%
19.23
+11.87%
17.19
+34.02%
12.83
Diluted EPS
1.75
+16.67%
1.50
+11.11%
1.35
+32.35%
1.02
Basic EPS
1.77
+16.45%
1.52
+11.76%
1.36
+33.33%
1.02
Basic Average Shares
12.72
+0.41%
12.67
+0.53%
12.60
+0.32%
12.56
Diluted Average Shares
12.85
+0.55%
12.78
+0.48%
12.72
+0.69%
12.64
Diluted NI Availto Com Stockholders
22.48
+16.88%
19.23
+11.87%
17.19
+34.02%
12.83
Gain On Sale Of PPE
0.20
+5175.00%
-0.00
+67.93%
-0.01
0.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
108.78
+10.63%
98.33
+6.70%
92.16
+7.77%
85.51
Current Assets
81.20
+7.92%
75.24
-1.00%
76.00
-1.92%
77.49
Cash Cash Equivalents And Short Term Investments
51.16
-2.06%
52.23
+4.97%
49.76
-14.15%
57.96
Cash And Cash Equivalents
51.16
-2.06%
52.23
+4.97%
49.76
-14.15%
57.96
Other Short Term Investments
—
—
—
0.00
Receivables
13.67
+29.47%
10.56
-13.65%
12.22
-7.91%
13.27
Accounts Receivable
13.67
+29.47%
10.56
-13.65%
12.22
-7.91%
13.27
Gross Accounts Receivable
13.86
+27.96%
10.83
-14.00%
12.59
-6.27%
13.44
Allowance For Doubtful Accounts Receivable
-0.19
+30.29%
-0.27
+25.71%
-0.37
-129.81%
-0.16
Inventory
11.62
+11.71%
10.40
-18.87%
12.82
+138.79%
5.37
Raw Materials
9.61
+6.53%
9.02
-16.71%
10.83
+124.42%
4.83
Work In Process
0.83
+46.30%
0.57
+13.33%
0.50
+35.54%
0.37
Finished Goods
1.73
+31.31%
1.32
-30.86%
1.91
+363.44%
0.41
Prepaid Assets
—
—
0.00
-100.00%
0.25
Other Current Assets
4.76
+132.05%
2.05
+71.77%
1.19
+89.15%
0.63
Total Non Current Assets
27.57
+19.45%
23.08
+42.89%
16.15
+101.33%
8.02
Net PPE
23.86
+41.91%
16.81
+48.35%
11.33
+146.07%
4.61
Gross PPE
28.93
+35.14%
21.41
+38.99%
15.40
+91.67%
8.04
Accumulated Depreciation
-5.07
-10.38%
-4.59
-12.90%
-4.07
-18.64%
-3.43
Properties
0.00
0.00
0.00
0.00
Land And Improvements
9.51
+52.13%
6.25
+0.00%
6.25
0.00
Buildings And Improvements
11.53
0.00
—
—
Machinery Furniture Equipment
7.87
+29.51%
6.07
+8.91%
5.58
+13.68%
4.91
Construction In Progress
0.02
-99.74%
8.81
+600.33%
1.26
+88.93%
0.67
Other Properties
—
0.15
-92.43%
2.04
-7.36%
2.21
Leases
0.00
-100.00%
0.27
-0.18%
0.27
+4.38%
0.26
Goodwill And Other Intangible Assets
3.38
+9.20%
3.10
+23.02%
2.52
+21.73%
2.07
Other Intangible Assets
3.38
+9.20%
3.10
+23.02%
2.52
+21.73%
2.07
Non Current Deferred Assets
0.09
-96.67%
2.82
+32.84%
2.12
+202.88%
0.70
Non Current Deferred Taxes Assets
—
2.82
+32.86%
2.12
+202.88%
0.70
Other Non Current Assets
0.24
-32.49%
0.35
+95.10%
0.18
-72.03%
0.65
Total Liabilities Net Minority Interest
14.16
+23.04%
11.51
-44.51%
20.74
+75.12%
11.84
Current Liabilities
10.18
+19.60%
8.51
-47.87%
16.33
+90.88%
8.55
Payables And Accrued Expenses
6.85
+20.89%
5.67
-56.27%
12.96
+170.42%
4.79
Payables
3.63
+91.67%
1.90
-81.39%
10.19
+430.20%
1.92
Accounts Payable
1.82
-4.01%
1.90
+2.10%
1.86
+3.21%
1.80
Dividends Payable
—
0.00
-100.00%
7.98
0.00
Current Accrued Expenses
3.22
-14.69%
3.77
+35.92%
2.78
-3.37%
2.87
Total Tax Payable
1.81
0.00
-100.00%
0.35
+189.77%
0.12
Income Tax Payable
1.81
0.00
-100.00%
0.25
0.00
Current Debt And Capital Lease Obligation
—
0.15
-64.19%
0.43
+45.83%
0.29
Current Capital Lease Obligation
—
0.15
-64.19%
0.43
+45.83%
0.29
Current Deferred Liabilities
2.87
+27.04%
2.26
-12.08%
2.57
-23.80%
3.37
Current Deferred Revenue
2.87
+27.04%
2.26
-12.08%
2.57
-23.80%
3.37
Other Current Liabilities
0.31
-32.83%
0.47
+86.40%
0.25
—
Total Non Current Liabilities Net Minority Interest
3.98
+32.82%
3.00
-32.07%
4.41
+34.12%
3.29
Long Term Debt And Capital Lease Obligation
0.00
-100.00%
0.00
-99.88%
1.62
-15.52%
1.91
Long Term Capital Lease Obligation
0.00
-100.00%
0.00
-99.88%
1.62
-15.52%
1.91
Non Current Deferred Liabilities
3.98
+32.91%
2.99
+7.14%
2.79
+103.14%
1.38
Non Current Deferred Revenue
3.98
+32.91%
2.99
+7.14%
2.79
+103.14%
1.38
Stockholders Equity
94.62
+8.98%
86.82
+21.56%
71.42
-3.06%
73.67
Common Stock Equity
94.62
+8.98%
86.82
+21.56%
71.42
-3.06%
73.67
Capital Stock
0.00
+0.00%
0.00
-20.95%
0.00
+0.48%
0.00
Common Stock
0.00
+0.00%
0.00
-20.95%
0.00
+0.48%
0.00
Share Issued
12.78
+0.57%
12.71
+0.39%
12.66
+0.55%
12.59
Ordinary Shares Number
12.78
+0.57%
12.71
+0.39%
12.66
+0.55%
12.59
Additional Paid In Capital
30.39
+1.20%
30.03
+6.63%
28.16
+6.64%
26.41
Retained Earnings
64.23
+13.10%
56.79
+31.28%
43.26
-8.48%
47.26
Gains Losses Not Affecting Retained Earnings
—
—
—
0.00
Total Equity Gross Minority Interest
94.62
+8.98%
86.82
+21.56%
71.42
-3.06%
73.67
Total Capitalization
94.62
+8.98%
86.82
+21.56%
71.42
-3.06%
73.67
Working Capital
71.02
+6.43%
66.73
+11.82%
59.67
-13.44%
68.94
Invested Capital
94.62
+8.98%
86.82
+21.56%
71.42
-3.06%
73.67
Total Debt
0.00
-100.00%
0.00
-99.90%
2.04
-7.36%
2.21
Capital Lease Obligations
0.00
-100.00%
0.00
-99.90%
2.04
-7.36%
2.21
Net Tangible Assets
91.23
+8.98%
83.72
+21.51%
68.90
-3.77%
71.60
Tangible Book Value
91.23
+8.98%
83.72
+21.51%
68.90
-3.77%
71.60
Current Provisions
0.14
+22.03%
0.12
+0.46%
0.12
+24.92%
0.09
Inventories Adjustments Allowances
-0.56
-9.25%
-0.51
-20.74%
-0.42
-75.83%
-0.24
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
24.95
-2.64%
25.62
+90.30%
13.47
+34.08%
10.04
Cash Flow From Continuing Operating Activities
24.95
-2.65%
25.62
+90.31%
13.47
+34.08%
10.04
Net Income From Continuing Operations
22.48
+16.88%
19.23
+11.87%
17.19
+34.02%
12.83
Depreciation Amortization Depletion
1.17
+42.54%
0.82
+6.90%
0.77
+14.09%
0.67
Depreciation
0.80
+35.84%
0.59
-9.59%
0.65
+13.80%
0.57
Amortization Cash Flow
0.37
+59.48%
0.23
+98.21%
0.12
+15.75%
0.10
Depreciation And Amortization
1.17
+42.54%
0.82
+6.90%
0.77
+14.09%
0.67
Amortization Of Intangibles
0.37
+59.48%
0.23
+98.21%
0.12
+15.75%
0.10
Other Non Cash Items
—
-0.00
—
—
Stock Based Compensation
2.92
+15.65%
2.52
+15.41%
2.19
+56.87%
1.39
Provisionand Write Offof Assets
-0.04
-428.57%
-0.01
-101.80%
0.39
+145.91%
0.16
Deferred Tax
2.73
+490.69%
-0.70
+40.44%
-1.17
-2152.49%
0.06
Deferred Income Tax
2.73
+490.69%
-0.70
+40.44%
-1.17
-2152.49%
0.06
Operating Gains Losses
0.04
+825.00%
0.00
-68.09%
0.01
+228.37%
-0.01
Gain Loss On Investment Securities
—
—
—
-0.01
Gain Loss On Sale Of PPE
0.04
+825.00%
0.00
-68.09%
0.01
+820.10%
-0.00
Change In Working Capital
-4.34
-215.87%
3.75
+163.45%
-5.91
-16.89%
-5.06
Change In Receivables
-3.03
-271.79%
1.76
+109.29%
0.84
+110.22%
-8.24
Changes In Account Receivables
-3.03
-271.79%
1.76
+109.29%
0.84
+110.22%
-8.24
Change In Inventory
-1.38
-144.05%
3.13
+141.86%
-7.47
-470.54%
-1.31
Change In Prepaid Assets
-2.71
-144.76%
-1.11
-258.63%
-0.31
-109.18%
3.36
Change In Payables And Accrued Expense
1.33
+584.10%
0.20
+158.75%
-0.33
-128.52%
1.16
Change In Accrued Expense
-0.55
-155.57%
1.00
+1130.10%
-0.10
-268.82%
0.06
Change In Payable
1.89
+335.41%
-0.80
-241.11%
-0.24
-121.25%
1.11
Change In Account Payable
-0.08
+91.18%
-0.86
-298.27%
-0.22
-119.24%
1.12
Change In Other Working Capital
1.62
+1574.55%
-0.11
-117.21%
0.64
+23.92%
0.52
Change In Other Current Assets
-0.04
-135.29%
-0.02
-103.64%
0.47
+217.33%
-0.40
Change In Other Current Liabilities
-0.15
-50.00%
-0.10
-140.00%
0.25
+270.72%
-0.15
Investing Cash Flow
-8.42
+4.49%
-8.82
-10.11%
-8.01
-482.34%
-1.37
Cash Flow From Continuing Investing Activities
-8.42
+4.49%
-8.82
-10.11%
-8.01
-482.34%
-1.37
Net PPE Purchase And Sale
-7.76
+3.00%
-8.01
-7.59%
-7.44
-804.05%
-0.82
Purchase Of PPE
-7.76
+3.00%
-8.01
-7.59%
-7.44
-804.05%
-0.82
Capital Expenditure
-8.42
+4.49%
-8.82
-10.11%
-8.01
-327.05%
-1.87
Capital Expenditure Reported
-0.66
+19.21%
-0.81
-43.30%
-0.57
+46.13%
-1.05
Net Investment Purchase And Sale
—
—
0.00
-100.00%
0.50
Sale Of Investment
—
—
0.00
-100.00%
0.50
Financing Cash Flow
-17.60
-22.77%
-14.34
-4.98%
-13.66
-7.48%
-12.71
Cash Flow From Continuing Financing Activities
-17.60
-22.77%
-14.34
-4.98%
-13.66
-7.48%
-12.71
Common Stock Dividend Paid
-15.04
-9.97%
-13.68
-3.43%
-13.22
-5.29%
-12.56
Cash Dividends Paid
-15.04
-9.97%
-13.68
-3.43%
-13.22
-5.29%
-12.56
Proceeds From Stock Option Exercised
0.00
-100.00%
0.03
-83.59%
0.18
+20.47%
0.15
Net Other Financing Charges
-2.56
-272.24%
-0.69
-12.72%
-0.61
-107.61%
-0.29
Changes In Cash
-1.07
-143.49%
2.47
+130.15%
-8.20
-103.00%
-4.04
Beginning Cash Position
52.23
+4.97%
49.76
-14.15%
57.96
-6.51%
62.00
End Cash Position
51.16
-2.06%
52.23
+4.97%
49.76
-14.15%
57.96
Free Cash Flow
16.53
-1.67%
16.81
+207.94%
5.46
-33.18%
8.17
Income Tax Paid Supplemental Data
3.92
-39.76%
6.51
+21.68%
5.35
+212.69%
1.71
Change In Income Tax Payable
1.96
+3173.33%
0.06
+421.23%
-0.02
-1.53%
-0.02
Change In Tax Payable
1.96
+3173.33%
0.06
+421.23%
-0.02
-1.53%
-0.02
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category